Anthony Doyle

Date	Company	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
19 Dec 24	BCRX BioCryst Pharmaceuticals	Common Stock	Payment of exercise	Dispose F	No	No	7.39	2,461	18.19 k	377,867
19 Dec 24	BCRX BioCryst Pharmaceuticals	Common Stock	Grant	Acquire A	No	No	0	120,700	0.00	380,328
19 Dec 24	BCRX BioCryst Pharmaceuticals	Emp. Stock Option Common Stock	Grant	Acquire A	No	No	7.39	250,100	1.85 mm	250,100
14 Dec 24	BCRX BioCryst Pharmaceuticals	Common Stock	Payment of exercise	Dispose F	No	No	7.53	7,890	59.41 k	259,628
14 May 24	BCRX BioCryst Pharmaceuticals	Common Stock	Buy	Acquire P	No	No	5.57	36,300	202.19 k	266,744
19 Dec 23	BCRX BioCryst Pharmaceuticals	Common Stock	Payment of exercise	Dispose F	No	No	6.05	2,482	15.02 k	227,444
14 Dec 23	BCRX BioCryst Pharmaceuticals	Common Stock	Payment of exercise	Dispose F	No	No	6.43	5,475	35.20 k	229,926
14 Dec 23	BCRX BioCryst Pharmaceuticals	Common Stock	Grant	Acquire A	No	No	0	34,000	0.00	235,401
14 Dec 23	BCRX BioCryst Pharmaceuticals	Emp. Stock Option Common Stock	Grant	Acquire A	No	No	6.43	158,500	1.02 mm	158,500

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.